Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 80201 - 80225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tretinoin	Approved Investigational Nutraceutical	ACO1	48	upregulated	Tretinoin results in increased expression of ACO1 mRNA	9p21.1	A24453
Tretinoin	Approved Investigational Nutraceutical	ACOT11	26027	downregulated	Tretinoin results in decreased expression of ACOT11 mRNA	1p32.3	A24453 A24456
Tretinoin	Approved Investigational Nutraceutical	ACP1	52	downregulated	Tretinoin results in decreased expression of ACP1 mRNA	2p25.3	A24454
Tretinoin	Approved Investigational Nutraceutical	ACSF3	197322	downregulated	Tretinoin results in decreased expression of ACSF3 mRNA	16q24.3	A24453
Tretinoin	Approved Investigational Nutraceutical	ACSL1	2180	upregulated	Tretinoin results in increased expression of ACSL1 mRNA	4q35.1	A24454
Tretinoin	Approved Investigational Nutraceutical	ACTA2	59	upregulated	Tretinoin results in increased expression of ACTA2 mRNA	10q23.31	A24459
Tretinoin	Approved Investigational Nutraceutical	ACTG1	71	downregulated	Tretinoin results in decreased expression of ACTG1 mRNA	17q25.3	A24453
Tretinoin	Approved Investigational Nutraceutical	ACTG2	72	upregulated	Tretinoin results in increased expression of ACTG2 mRNA	2p13.1	A20711
Tretinoin	Approved Investigational Nutraceutical	ACTL6B	51412	upregulated	Tretinoin results in increased expression of ACTL6B mRNA	7q22.1	A24460
Tretinoin	Approved Investigational Nutraceutical	ACTN2	88	downregulated	Tretinoin results in decreased expression of ACTN2 mRNA	1q43	A24453
Tretinoin	Approved Investigational Nutraceutical	ACTN3	89	downregulated	Tretinoin results in decreased expression of ACTN3 mRNA	11q13.2	A24454
Tretinoin	Approved Investigational Nutraceutical	ACVRL1	94	downregulated	Tretinoin results in decreased expression of ACVRL1 mRNA	12q13.13	A24376
Tretinoin	Approved Investigational Nutraceutical	ADA	100	upregulated	Tretinoin results in increased expression of ADA mRNA	20q13.12	A24376 A20711
Tretinoin	Approved Investigational Nutraceutical	ADAM10	102	upregulated	Tretinoin results in increased expression of ADAM10 mRNA	15q21.3	A24461 A24462 A24463
Tretinoin	Approved Investigational Nutraceutical	ADAM19	8728	upregulated	Tretinoin results in increased expression of ADAM19 mRNA	5q33.3	A24453 A24456
Tretinoin	Approved Investigational Nutraceutical	ADAM23	8745	downregulated	Tretinoin results in decreased expression of ADAM23 mRNA	2q33.3	A24454 A24453
Tretinoin	Approved Investigational Nutraceutical	ADAM8	101	upregulated	Tretinoin results in increased expression of ADAM8 mRNA	10q26.3	A24453
Tretinoin	Approved Investigational Nutraceutical	ADAM9	8754	upregulated	Tretinoin results in increased expression of ADAM9 mRNA	8p11.22	A24463 A24454
Tretinoin	Approved Investigational Nutraceutical	ADAMTS1	9510	upregulated	Tretinoin results in increased expression of ADAMTS1 mRNA	21q21.3	A24454
Tretinoin	Approved Investigational Nutraceutical	ADAMTS18	170692	upregulated	Tretinoin results in increased expression of ADAMTS18 mRNA	16q23.1	A24454
Tretinoin	Approved Investigational Nutraceutical	ADAMTS19	171019	upregulated	Tretinoin results in increased expression of ADAMTS19 mRNA	5q23.3	A24454
Tretinoin	Approved Investigational Nutraceutical	ADAMTS3	9508	upregulated	Tretinoin results in increased expression of ADAMTS3 mRNA	4q13.3	A24454
Tretinoin	Approved Investigational Nutraceutical	ADAMTS4	9507	downregulated	Tretinoin results in decreased expression of ADAMTS4 mRNA	1q23.3	A24453
Tretinoin	Approved Investigational Nutraceutical	ADAMTS5	11096	upregulated	Tretinoin results in increased expression of ADAMTS5 mRNA	21q21.3	A24454
Tretinoin	Approved Investigational Nutraceutical	ADAMTS6	11174	downregulated	Tretinoin results in decreased expression of ADAMTS6 mRNA	5q12.3	A24454

Displaying entries 80201 - 80225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability